295 related articles for article (PubMed ID: 12015813)
1. Apolipoprotein E structural requirements for the formation of SDS-stable complexes with beta-amyloid-(1-40): the role of salt bridges.
Bentley NM; Ladu MJ; Rajan C; Getz GS; Reardon CA
Biochem J; 2002 Aug; 366(Pt 1):273-9. PubMed ID: 12015813
[TBL] [Abstract][Full Text] [Related]
2. Contribution of cysteine 158, the glycosylation site threonine 194, the amino- and carboxy-terminal domains of apolipoprotein E in the binding to amyloid peptide beta (1-40).
Aleshkov SB; Li X; Lavrentiadou SN; Zannis VI
Biochemistry; 1999 Jul; 38(28):8918-25. PubMed ID: 10413465
[TBL] [Abstract][Full Text] [Related]
3. Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer's disease.
Aleshkov S; Abraham CR; Zannis VI
Biochemistry; 1997 Aug; 36(34):10571-80. PubMed ID: 9265639
[TBL] [Abstract][Full Text] [Related]
4. SDS-stable complex formation between native apolipoprotein E3 and beta-amyloid peptides.
Munson GW; Roher AE; Kuo YM; Gilligan SM; Reardon CA; Getz GS; LaDu MJ
Biochemistry; 2000 Dec; 39(51):16119-24. PubMed ID: 11123940
[TBL] [Abstract][Full Text] [Related]
5. ApoE and Abeta1-42 interactions: effects of isoform and conformation on structure and function.
Manelli AM; Stine WB; Van Eldik LJ; LaDu MJ
J Mol Neurosci; 2004; 23(3):235-46. PubMed ID: 15181252
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3.
Sanan DA; Weisgraber KH; Russell SJ; Mahley RW; Huang D; Saunders A; Schmechel D; Wisniewski T; Frangione B; Roses AD
J Clin Invest; 1994 Aug; 94(2):860-9. PubMed ID: 8040342
[TBL] [Abstract][Full Text] [Related]
7. Structural variation in human apolipoprotein E3 and E4: secondary structure, tertiary structure, and size distribution.
Chou CY; Lin YL; Huang YC; Sheu SY; Lin TH; Tsay HJ; Chang GG; Shiao MS
Biophys J; 2005 Jan; 88(1):455-66. PubMed ID: 15475580
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the binding of amyloid-beta peptide to cell culture-derived native apolipoprotein E2, E3, and E4 isoforms and to isoforms from human plasma.
Yang DS; Smith JD; Zhou Z; Gandy SE; Martins RN
J Neurochem; 1997 Feb; 68(2):721-5. PubMed ID: 9003062
[TBL] [Abstract][Full Text] [Related]
9. Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formation.
Buttini M; Yu GQ; Shockley K; Huang Y; Jones B; Masliah E; Mallory M; Yeo T; Longo FM; Mucke L
J Neurosci; 2002 Dec; 22(24):10539-48. PubMed ID: 12486146
[TBL] [Abstract][Full Text] [Related]
10. Effect of apolipoprotein AII on the interaction of apolipoprotein E with beta-amyloid: some apo(E-AII) complexes inhibit the internalization of beta-amyloid in cultures of neuroblastoma cells.
Yamauchi K; Tozuka M; Hidaka H; Nakabayashi T; Sugano M; Kondo Y; Nakagawara A; Katsuyama T
J Neurosci Res; 2000 Nov; 62(4):608-14. PubMed ID: 11070505
[TBL] [Abstract][Full Text] [Related]
11. Association of human, rat, and rabbit apolipoprotein E with beta-amyloid.
LaDu MJ; Lukens JR; Reardon CA; Getz GS
J Neurosci Res; 1997 Jul; 49(1):9-18. PubMed ID: 9211985
[TBL] [Abstract][Full Text] [Related]
12. Isoform-specific interactions of human apolipoprotein E to an intermediate conformation of human Alzheimer amyloid-beta peptide.
Stratman NC; Castle CK; Taylor BM; Epps DE; Melchior GW; Carter DB
Chem Phys Lipids; 2005 Oct; 137(1-2):52-61. PubMed ID: 16140289
[TBL] [Abstract][Full Text] [Related]
13. Specific modulation of the fusogenic properties of the Alzheimer beta-amyloid peptide by apolipoprotein E isoforms.
Pillot T; Goethals M; Vanloo B; Lins L; Brasseur R; Vandekerckhove J; Rosseneu M
Eur J Biochem; 1997 Feb; 243(3):650-9. PubMed ID: 9057828
[TBL] [Abstract][Full Text] [Related]
14. Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease.
Strittmatter WJ; Weisgraber KH; Huang DY; Dong LM; Salvesen GS; Pericak-Vance M; Schmechel D; Saunders AM; Goldgaber D; Roses AD
Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8098-102. PubMed ID: 8367470
[TBL] [Abstract][Full Text] [Related]
15. Lipidation of apolipoprotein E influences its isoform-specific interaction with Alzheimer's amyloid beta peptides.
Tokuda T; Calero M; Matsubara E; Vidal R; Kumar A; Permanne B; Zlokovic B; Smith JD; Ladu MJ; Rostagno A; Frangione B; Ghiso J
Biochem J; 2000 Jun; 348 Pt 2(Pt 2):359-65. PubMed ID: 10816430
[TBL] [Abstract][Full Text] [Related]
16. The interaction of amyloid-beta with ApoE.
Carter DB
Subcell Biochem; 2005; 38():255-72. PubMed ID: 15709483
[TBL] [Abstract][Full Text] [Related]
17. High-affinity multivalent interactions between apolipoprotein E and the oligomers of amyloid-β.
Ghosh S; Sil TB; Dolai S; Garai K
FEBS J; 2019 Dec; 286(23):4737-4753. PubMed ID: 31287614
[TBL] [Abstract][Full Text] [Related]
18. Structural variation manipulates the differential oxidative susceptibility and conformational stability of apolipoprotein E isoforms.
Su KL; Wen TH; Chou CY; Chang GG; Liu GY; Hung HC
Proteins; 2007 Jul; 68(1):363-74. PubMed ID: 17410580
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E and oxidative stress in brain with relevance to Alzheimer's disease.
Butterfield DA; Mattson MP
Neurobiol Dis; 2020 May; 138():104795. PubMed ID: 32036033
[TBL] [Abstract][Full Text] [Related]
20. Purification of apolipoprotein E attenuates isoform-specific binding to beta-amyloid.
LaDu MJ; Pederson TM; Frail DE; Reardon CA; Getz GS; Falduto MT
J Biol Chem; 1995 Apr; 270(16):9039-42. PubMed ID: 7721816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]